Trimi review

Trimi publishes two prices for semaglutide and means both: $175 a month with no commitment, or $99 a month if you pay $1,188 once for the year. Tirzepatide runs $235 month to month, or $125 a month on a $1,500 annual charge. The honesty is the most useful thing about the company. The cheap number and the condition attached to it sit in the same table on the same product page, with no coupon hunt and no qualifier hidden in a footer.

There are two rungs in between on each molecule. Semaglutide is $435 billed every three months, which works out to $145, or $720 every six months at $120. Tirzepatide is $597 quarterly at $199, or $1,050 for six months at $175. Trimi's own prose states the range plainly: "compounded semaglutide costs $99-175 per month depending on billing plan." Those middle rungs are where a lot of people should probably land, since they cut the monthly rate meaningfully without asking for the whole year in one charge.

Run the rungs out to a full year and the gaps get concrete. Semaglutide at $175 month to month is $2,100 over twelve months; the quarterly plan is $1,740, the six-month plan $1,440, and the annual plan $1,188. Tirzepatide goes $2,820, then $2,388, then $2,100, then $1,500. Trimi's own tables agree with that arithmetic, labeling the annual plans "Save $912 vs monthly" and "Save $1,320 vs monthly." The jump from monthly to quarterly is the biggest single step on either molecule and costs only three months of commitment, which makes it the rung worth looking at hardest if the twelve-month charge is more than you want to hand over on day one.

One fee covers the rest of it. Trimi's page says the membership includes "your medication, clinician visits, ongoing check-ins, and free shipping. No surprise charges," and the annual footnote confirms the $99 rate "includes the telehealth visit and free shipping." Dose escalation does not move the number either: "Same price at every dose. Your price never changes as your dose is adjusted." The figure you choose at signup is the figure you keep.

The billing cycle is a real calendar month rather than a 28-day cycle, so the monthly plan is twelve charges a year and not thirteen. There is no first-month teaser that resets in month two. The 50OFF first-month promotion the site was running earlier in August is no longer on the homepage as of August 28, 2026. A separate discount-codes page exists and was not checked, so treat any code as a bonus rather than part of your budget.

Coverage is all 50 states, stated on the homepage product cards as "licensed clinicians via Arora Health, all 50 states," with a dedicated availability page behind it. That is a firmer position than CoreAge Rx, which ranks first here but whose own FAQ says restrictions may apply by state and get confirmed during intake. If you live somewhere that has given you trouble with telehealth prescribing before, Trimi at least states its answer before you hand over any information.

Everything is compounded. There is no FDA-approved Wegovy or Zepbound path and no oral or sublingual form. The public track record is shorter than the older flat-fee names covered here. And $175 is not the lowest month-to-month semaglutide price on this site, so if a single cheap month is the whole goal, Trimi is not where that ends. Its argument is the ladder, not the floor.

It suits someone who wants to start without betting a year, then step the price down once the drug is clearly working for them. The $175 month gets you moving and the six-month rung at $120 is waiting when you are ready. It suits tirzepatide buyers especially: at $125 the twelve-month rate undercuts every other partner we track that publishes a firm tirzepatide rate rather than a starting figure, though it does take $1,500 in one charge to reach it. One practical note before you search: the company's site is trytrimi.com. The bare trimi.com is an unrelated site with no connection to it.